Bengaluru-based healthtech firm Indegene on Wednesday said it has raised $200 million from US-based investment firms Carlyle Group and Brighton Park Capital. The company has reportedly been valued at $650-700 million. Founded in 1998, Indegene claims to be working with 75 of the world's largest pharma companies, helping them prepare legally compliant clinical data for trials.